Simple blood test could transform iron monitoring in thalassemia

NCT ID NCT07486531

Completed Knowledge-focused Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new, simpler method to measure iron buildup inside red blood cells of people with beta thalassemia major. The goal was to find a cheaper and easier way to monitor iron overload compared to current tests. Researchers analyzed blood samples from 100 patients to see if this method could work in everyday clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this method could offer a simpler, cheaper way to monitor iron overload in thalassemia patients, helping guide treatment decisions.
What could go wrong: This is a small, completed observational study, not a treatment trial. The method needs further validation before it can be used in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BETA-THALASSEMIA MAJOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

beta thalassemia beta-thalassemia major Iron Overload

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BETA-THALASSEMIA MAJOR

Contacts and locations

Locations

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.